Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-19-047348)

Filing Details

Accession Number:: 0001104659-19-047348
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2019-08-26 21:35:03
Reporting Period:: 2019-08-21

Accepted Time:: 2019-08-26 21:35:03
Original Submission Date:: 2019-08-21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1641640	Nabriva Therapeutics Plc	NBRV	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1659085	Gary Sender	1000 Continental Drive Suite 600 King Of Prussia PA 19406	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2019-08-21	3,390	$2.08	19,214	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This amendment is being filed solely to correct the transaction code from "F" to "S" for the sale of ordinary shares to satisfy tax withholding obligations in connection with the transaction reported in the Form 4 filed by the reporting person on August 21, 2019.